Friday, 26 April 2019

AstraZeneca's first-quarter sales beat estimates on aggressive push into cancer drugs

AstraZeneca reported first-quarter product sales and earnings ahead of analysts' expectations.

from Earnings https://cnb.cx/2UCZto4
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)